Trial Profile
Phase I trial of AL-516 for the treatment of chronic hepatitis C
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 15 Jun 2015
Price :
$35
*
At a glance
- Drugs AL 516 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 15 Jun 2015 New trial record